๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Risperidone - Medicines in Ireland

40 authorised products containing Risperidone, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 40 authorised medicines
MedicineActive substanceLicence holderStatus
OKEDI 100 mg Powder and solvent for prolonged-release suspension for injection
EU/1/21/1621/002
Risperidone Laboratorios Farmacรฉuticos ROVI, S.A. โ€”
OKEDI 75 mg Powder and solvent for prolonged-release suspension for injection
EU/1/21/1621/001
Risperidone Laboratorios Farmacรฉuticos ROVI, S.A. โ€”
Perdamel 0.5 mg film-coated tablets
PA0126/169/002
Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 1 mg film-coated tablets
PA0126/169/003
Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 2 mg film-coated tablets
PA0126/169/004
Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 3 mg film-coated tablets
PA0126/169/005
Risperidone Clonmel Healthcare Ltd Marketed
Perdamel 4 mg film-coated tablets
PA0126/169/006
Risperidone Clonmel Healthcare Ltd Marketed
RISPERDAL 0.5 mg film-coated tablets
PA22612/010/009
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 1 mg film-coated tablets
PA22612/010/004
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 1 mg/ml oral solution
PA22612/010/001
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 1 mg/ml oral solution
PPA2306/007/001
Risperidone Originalis B.V. โ€”
RISPERDAL 1 mg/ml oral solution
PPA1463/227/001
Risperidone IMED Healthcare Ltd., โ€”
RISPERDAL 1 mg/ml oral solution
PPA0465/525/001
Risperidone PCO Manufacturing Ltd. โ€”
RISPERDAL 2 mg film-coated tablets
PA22612/010/005
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 3 mg film-coated tablets
PA22612/010/006
Risperidone Janssen Sciences Ireland Unlimited Company Not marketed
RISPERDAL 4 mg film-coated tablets
PA22612/010/007
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 6 mg film-coated tablets
PA22612/010/002
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/010
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/011
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 50 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/012
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
Risperidone 1 mg/ml oral solution
PA0281/248/001
Risperidone Pinewood Laboratories Ltd Not marketed
Risperidone Grindeks 0.5 mg film-coated tablets
PA22992/021/001
Risperidone AS Grindeks Not marketed
Risperidone Grindeks 1 mg film-coated tablets
PA22992/021/002
Risperidone AS Grindeks Not marketed
Risperidone Grindeks 2 mg film-coated tablets
PA22992/021/003
Risperidone AS Grindeks Not marketed
Risperidone Grindeks 3 mg film-coated tablets
PA22992/021/004
Risperidone AS Grindeks Not marketed
Risperidone Grindeks 4 mg film-coated tablets
PA22992/021/005
Risperidone AS Grindeks Not marketed
Risperidone Grindeks 6 mg film-coated tablets
PA22992/021/006
Risperidone AS Grindeks Not marketed
Rispeva 0.5 mg film-coated tablets
PA1986/021/001
Risperidone Teva B.V. Marketed
Rispeva 1 mg film-coated tablets
PA0749/049/007
Risperidone Teva Pharma B.V. Marketed
Rispeva 2 mg film-coated tablets
PA0749/049/008
Risperidone Teva Pharma B.V. Marketed
Rispeva 3 mg film-coated tablets
PA0749/049/009
Risperidone Teva Pharma B.V. Marketed
Rispeva 4 mg film-coated tablets
PA0749/049/010
Risperidone Teva Pharma B.V. Marketed
Rispone 0.5 mg film-coated tablets
PA0711/106/002
Risperidone Rowex Limited, Marketed
Rispone 1 mg film-coated tablets
PA0711/106/006
Risperidone Rowex Limited, Marketed
Rispone 1 mg/ml oral solution
PA0711/106/001
Risperidone Rowex Limited, Marketed
Rispone 2 mg film-coated tablets
PA0711/106/007
Risperidone Rowex Limited, Marketed
Rispone 3 mg film-coated tablets
PA0711/106/008
Risperidone Rowex Limited, Marketed
Sperizak 25 mg powder and solvent for prolonged-release suspension for injection
PA2315/248/001
Risperidone Accord Healthcare Ireland Ltd. Marketed
Sperizak 37.5 mg powder and solvent for prolonged-release suspension for injection
PA2315/248/002
Risperidone Accord Healthcare Ireland Ltd. Marketed
Sperizak 50 mg powder and solvent for prolonged-release suspension for injection
PA2315/248/003
Risperidone Accord Healthcare Ireland Ltd. Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.